Market Tracker

06/23 5:16pm ET

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

1.65
Delayed Data
As of Jun 23
 -0.17 / -9.34%
Today’s Change
1.54
Today|||52-Week Range
32.00
-68.23%
Year-to-Date
No recent news for Anthera Pharmaceuticals Inc.

Today’s Trading

Previous close1.82
Today’s open1.80
Day’s range1.65 - 1.83
Volume1,170,703
Average volume (3 months)324,143
Market cap$16.6M
Dividend yield--
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-62.63%
Earnings growth (this year)--
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)-95.45%
P/E ratioNM
Price/Sales184.93
Price/Book2.46

Competitors

 Today’s
change
Today’s
% change
EPIXESSA Pharma Inc-0.02-2.59%
ARGSArgos Therapeutics I...-0.03-6.52%
NVGNNovogen Ltd-0.01-1.11%
CYCCCyclacel Pharmaceuti...-0.13-3.06%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 1, 2017
EPS forecast (this quarter)-$1.09
Annual revenue (last year)$145.0K
Annual profit (last year)-$55.5M
Net profit margin-38,291.72%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Craig Thompson
CAO, Senior VP-Finance &
Administration
May Liu
Corporate headquarters
Hayward, California

Forecasts